Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Study to Assess the Efficacy and Safety of SBG on Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy With or Without Chemotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Aug 2022
Price :
$35
*
At a glance
- Drugs Soluble beta 1,3-1,6 glucan (Primary)
- Indications Mucositis
- Focus Therapeutic Use
- Sponsors Biotec Pharmacon
- 18 Dec 2014 New trial record